Caption Management »

Oric Pharmaceuticals shares owned by Caption Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 495k 9.20
2023-06-30 $457k 59k 7.76

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
Column Group
EcoR1 Capital
VR Adviser
Vanguard Group
Frazier Life Sciences Management
Arrowpoint Asset Management
Boxer Capital
Invus Financial Advisors
Euclidean Capital
Vivo Capital
Franklin Resources
Henderson Group
T. Rowe Price Associates
OrbiMed Advisors

View all funds holding Oric Pharmaceuticals